ResearcherCentre National de la Recherche ScientifiqueNo recent work listed

Yousra Mohamed Abd-El-Halim

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5019750065. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2021: 1 paper

Papers 1

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. Co-author DOI 10.1016/j.ebiom.2021.103541 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Julie Roques · 1 shared paper, 2021 · strength 0.12
- Paper A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. DOI 10.1016/j.ebiom.2021.103541 ↗
Rémy Nicolle · 1 shared paper, 2021 · strength 0.12
- Paper A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. DOI 10.1016/j.ebiom.2021.103541 ↗
Jerome F. Cros · 1 shared paper, 2021 · strength 0.12
- Paper A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. DOI 10.1016/j.ebiom.2021.103541 ↗
Eric Mas · 1 shared paper, 2021 · strength 0.12
- Paper A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. DOI 10.1016/j.ebiom.2021.103541 ↗
Abdessamad El Kaoutari · 1 shared paper, 2021 · strength 0.12
- Paper A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. DOI 10.1016/j.ebiom.2021.103541 ↗
Juan Iovanna · 1 shared paper, 2021 · strength 0.12
- Paper A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. DOI 10.1016/j.ebiom.2021.103541 ↗
Nelson Dusetti · 1 shared paper, 2021 · strength 0.12
- Paper A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. DOI 10.1016/j.ebiom.2021.103541 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.